Total skin electron beam therapy for cutaneous T-cell lymphoma: A nationwide cohort study from Denmark

References

• Lenane P, Powell FC, O'Keane C, Dervan P, O'Sullivan D, Bourke E, . Mycosis fungoides – a review of the management of 28 patients and of the recent literature. Int J Dermatol 2007;46:19–26.
   PubMed Web of Science ®Google Scholar
• Ysebaert L, Truc G, Dalac S, Lambert D, Petrella T, Barillot I, . Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation). Int J Radiat Oncol Biol Phys 2004;58:1128–34.
   PubMed Web of Science ®Google Scholar
• Wilson LD, Kacinski BM, Jones GW. Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiat Oncol Biol Phys 1998;40:109–15.
   PubMed Web of Science ®Google Scholar
• Kuzel TM, Roenigk HH, Jr., Rosen ST. Mycosis fungoides and the Sezary syndrome: A review of pathogenesis, diagnosis, and therapy. J Clin Oncol 1991;9:1298–313.
   PubMed Web of Science ®Google Scholar
• Hoppe RT. Mycosis fungoides: Radiation therapy. Dermatol Ther 2003;16:347–54.
   PubMedGoogle Scholar
• Chinn DM, Chow S, Kim YH, Hoppe RT. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides. Int J Radiat Oncol Biol Phys 1999; 43:951–8.
   PubMed Web of Science ®Google Scholar
• Hoppe RT, Wood GS, Abel EA. Mycosis fungoides and the Sezary syndrome: Pathology, staging, and treatment. Curr Probl Cancer 1990;14:293–371.
   PubMed Web of Science ®Google Scholar
• Kamstrup MR, Specht L, Skovgaard GL, Gniadecki R. A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides. Int J Radiat Oncol Biol Phys 2008;71:1204–7.
   PubMed Web of Science ®Google Scholar
• Cox RS, Heck RJ, Fessenden P, Karzmark CJ, Rust DC. Development of total-skin electron therapy at two energies. Int J Radiat Oncol Biol Phys 1990;18:659–69.
   PubMed Web of Science ®Google Scholar
• Hoppe RT, Fuks Z, Bagshaw MA. Radiation therapy in the management of cutaneous T-cell lymphomas. Cancer Treat Rep 1979;63:625–32.
   PubMedGoogle Scholar
• Karzmark CJ, Anderson J, Buffa A, Fessenden P, Kahn F, Svensson G, . Total skin electron therapy technique and dosimetry. AAMP Report No. 23. New York: American Institute of Physics; 1988.
   Google Scholar
• Jones GW, Tadros A, Hodson DI, Rosenthal D, Roberts J, Thorson B. Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 Gy. Int J Radiat Oncol Biol Phys 1994;28:839–45.
   PubMed Web of Science ®Google Scholar
• Funk A, Hensley F, Krempien R, Neuhof D, Van Kampen M, Treiber M, . Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma. Eur J Dermatol 2008;18:308–12.
   PubMed Web of Science ®Google Scholar
• Hoppe RT. Total skin electron beam therapy in the management of mycosis fungoides. Front Radiat Ther Oncol 1991; 25:80–9.
   PubMedGoogle Scholar
• Kim YH, Chow S, Varghese A, Hoppe RT. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 1999;135:26–32.
   PubMed Web of Science ®Google Scholar
• Jones GW, Hoppe RT, Glatstein E. Electron beam treatment for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995;9:1057–76.
   PubMed Web of Science ®Google Scholar
• Wilson LD, Cooper DL, Goodrich AL, Friedman ND, Feldman AM, Braverman IM. Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys 1994;28: 829–37.
   PubMed Web of Science ®Google Scholar
• Jones GW, Rosenthal D, Wilson LD. Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sezary syndrome). Cancer 1999;85:1985–95.
   PubMed Web of Science ®Google Scholar
• Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 1996; 132:1309–13.
   PubMed Web of Science ®Google Scholar
• Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: Clinical prognostic factors and risk for disease progression. Arch Dermatol 2003;139:857–66.
   PubMed Web of Science ®Google Scholar